WO1997047745A1 - Proteines vegetales associees au retinoblastome - Google Patents
Proteines vegetales associees au retinoblastome Download PDFInfo
- Publication number
- WO1997047745A1 WO1997047745A1 PCT/EP1997/003070 EP9703070W WO9747745A1 WO 1997047745 A1 WO1997047745 A1 WO 1997047745A1 EP 9703070 W EP9703070 W EP 9703070W WO 9747745 A1 WO9747745 A1 WO 9747745A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- plant
- nucleic acid
- dna
- cell
- Prior art date
Links
- 102100038042 Retinoblastoma-associated protein Human genes 0.000 title 1
- 101710124357 Retinoblastoma-associated protein Proteins 0.000 title 1
- 241000196324 Embryophyta Species 0.000 claims abstract description 54
- 108050002653 Retinoblastoma protein Proteins 0.000 claims abstract description 34
- 241001465754 Metazoa Species 0.000 claims abstract description 17
- 241000700605 Viruses Species 0.000 claims abstract description 17
- 239000013598 vector Substances 0.000 claims abstract description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 4
- 235000013311 vegetables Nutrition 0.000 claims abstract description 4
- 230000010261 cell growth Effects 0.000 claims abstract description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 54
- 102000004169 proteins and genes Human genes 0.000 claims description 47
- 108020004414 DNA Proteins 0.000 claims description 23
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 20
- 150000007523 nucleic acids Chemical class 0.000 claims description 19
- 108020004707 nucleic acids Proteins 0.000 claims description 18
- 102000039446 nucleic acids Human genes 0.000 claims description 18
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 230000012010 growth Effects 0.000 claims description 14
- 239000002299 complementary DNA Substances 0.000 claims description 11
- 230000014509 gene expression Effects 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 240000008042 Zea mays Species 0.000 claims description 10
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- 235000009973 maize Nutrition 0.000 claims description 10
- 241000702463 Geminiviridae Species 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 230000003612 virological effect Effects 0.000 claims description 9
- 101000742859 Homo sapiens Retinoblastoma-associated protein Proteins 0.000 claims description 8
- 230000010076 replication Effects 0.000 claims description 8
- 108020004511 Recombinant DNA Proteins 0.000 claims description 6
- 201000000582 Retinoblastoma Diseases 0.000 claims description 5
- 231100000219 mutagenic Toxicity 0.000 claims description 5
- 230000003505 mutagenic effect Effects 0.000 claims description 5
- 108020004491 Antisense DNA Proteins 0.000 claims description 4
- 108020005544 Antisense RNA Proteins 0.000 claims description 4
- 239000003816 antisense DNA Substances 0.000 claims description 4
- 239000003184 complementary RNA Substances 0.000 claims description 4
- 125000006850 spacer group Chemical group 0.000 claims description 4
- 102000007079 Peptide Fragments Human genes 0.000 claims description 2
- 108010033276 Peptide Fragments Proteins 0.000 claims description 2
- 108091023040 Transcription factor Proteins 0.000 claims description 2
- 102000040945 Transcription factor Human genes 0.000 claims description 2
- 231100000350 mutagenesis Toxicity 0.000 claims description 2
- 238000002703 mutagenesis Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000010348 incorporation Methods 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 44
- 210000004102 animal cell Anatomy 0.000 abstract description 6
- 230000001413 cellular effect Effects 0.000 abstract description 2
- 238000002955 isolation Methods 0.000 abstract description 2
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 33
- 239000013612 plasmid Substances 0.000 description 25
- 241000702302 Wheat dwarf virus Species 0.000 description 21
- 101710090029 Replication-associated protein A Proteins 0.000 description 14
- 230000004543 DNA replication Effects 0.000 description 13
- 230000003993 interaction Effects 0.000 description 7
- 108091033319 polynucleotide Proteins 0.000 description 7
- 102000040430 polynucleotide Human genes 0.000 description 7
- 239000002157 polynucleotide Substances 0.000 description 7
- 108050006400 Cyclin Proteins 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 101000621041 Homo sapiens Retinoblastoma-like protein 2 Proteins 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 230000018199 S phase Effects 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 102000016736 Cyclin Human genes 0.000 description 4
- 102100039556 Galectin-4 Human genes 0.000 description 4
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 108050002651 Retinoblastoma-like protein 2 Proteins 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 108020005202 Viral DNA Proteins 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 229960005542 ethidium bromide Drugs 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 230000010190 G1 phase Effects 0.000 description 2
- 102100036220 PC4 and SFRS1-interacting protein Human genes 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 102000009339 Proliferating Cell Nuclear Antigen Human genes 0.000 description 2
- 101710150114 Protein rep Proteins 0.000 description 2
- 101710152114 Replication protein Proteins 0.000 description 2
- 235000014548 Rubus moluccanus Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 108091092356 cellular DNA Proteins 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 102000027450 oncoproteins Human genes 0.000 description 2
- 108091008819 oncoproteins Proteins 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 238000001086 yeast two-hybrid system Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 1
- 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 1
- 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 1
- 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
- 102000019274 E2F Family Human genes 0.000 description 1
- 108050006730 E2F Family Proteins 0.000 description 1
- 108091060211 Expressed sequence tag Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 101150009006 HIS3 gene Proteins 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101710193533 Protein RepA Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000235343 Saccharomycetales Species 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 230000006369 cell cycle progression Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 108020001568 subdomains Proteins 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000005748 tumor development Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 238000010396 two-hybrid screening Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the present invention relates the proteins having biological activity in plant and animal systems, to polynucleotides encoding for the expression of such proteins, to oligonucleotides for use in identifying and synthesizing these proteins and polynucleotides, to vectors and cells containing the polynucleotides in recombinant form and to plants and animals comprising these, and to the use of the proteins and polynucleotides and fragments thereof in the control of plant growth and plant vulnerability to viruses.
- Rb retinoblastoma susceptibility gene
- DNA tumor viruses that infect animal cells express oncoproteins that interact with the Rb protein via a LXCXE motif, disrupting Rb-E2F complexes and driving cells into S-phase (Weinberg ibid; Ludlow, J. W FASEB J. 7, 866 (1993); Moran, E. FASEB J. 7, 880 (1993); Vousden, K. FASEB J. 7, 872 (1993)).
- the present inventors have shown that efficient replication of a plant geminivirus requires the integrity of an LXCXE amino acid motif in the viral RepA protein and that RepA can interact with members of the human Rb family in yeast (Xie, Q., Suarez-L ⁇ pez, P. and Gutierrez, C. EMBO J. 14, 4073 (1995).
- the presence of the LXCXE motif ni plant D-type cyclins has also been reported (Soni, R., Carmichael, J. P., Shah, Z. H. and Murray, J. A. H. Plant Cell 7, 85-103 (1995)).
- the present inventors have now identified characteristic sequences of plant Rb proteins and corresponding encoding polynucleotides for the first time, isolated such a protein and polynucleotide, and particularly have identified sequences that distinguish it from known animal Rb protein sequences.
- the inventors have determined that a known DNA sequence from the maize encoding a vegetable Rb plant protein and is hereinafter called ZmRb1.
- ZmRb1 has been demonstrated by the inventors to interact in yeasts with RepA, a plant geminivirus protein containing LXCXE motif essential for its function.
- the inventors have further determined that geminivirus DNA replication is reduced in plant cells transfected with plasmids encoding either ZmRb1 or human pl30, a member of the human Rb family.
- plant and animal cells may share fundamentally similar strategies for growth control, and thus human as well as plant Rb protein such as ZmRb1 will be expected to have utility in, in ter alia , plant therapeutics, diagnostics, growth control or investigations and many such plant proteins will have similar utility in animals.
- retinoblastoma protein in controlling the growth of plant cells and/or plant viruses.
- the present invention provides control of viral infection and/or growth in plant cells wherein the virus requires the integrity of an LXCXE amino acid motif in one of its proteins, particularly, e. g., in the viral RepA protein, for normal reproduction.
- Particular plant viruses so controlled are Geminiviruses.
- a preferred method of control using such proteins involves applying these to the plant cell, either directly or by introduction of DNA or RNA encoding for their expression into the plant cell which it is desired to treat.
- anti-sense DNA or RNA in plant cells in vectors form that contain the necessary promoters for the DNA or RNA transcription, it will be possible to exploit the well known anti-sense mechanism in order to inhibit the expression of the Rb protein, and thus the S-phase.
- Such plants will be of use, among other aspects to replicate DNA or RNA until high levels, e.g. in yeasts.
- the methods to introduce anti -sense DNA in cells are very well known for those skilled in the art: see for example "Principles of gene manipulation - An introduction to Genetic Engineering (1994) R.W. Old & S.B. Primrose; Oxford-Blackwell Scientific Publications Fifth Edition p398.
- nucleic acid in a second aspect of the present invention there is provided recombinant nucleic acid, particularly in the form of DNA or cRNA (mRNA) , encoding for expression of Rb protein that is characteristic of plants.
- This nucleic acid is characterised by one or more characteristic regions that differ from known animal Rb protein nucleic acid and is exemplified herein by SEQ ID No 1, bases 31- 2079.
- the DNA or RNA can have a sequence that contains the degenerated substitution in the nucleotides of the codons in SEQ ID No. 1, and in where the RNA the T is U.
- the most preferred DNA or RNA are capable of hybridate with the polynucleotide of the SEQ ID No. 1 in conditions of low stringency, preferably being the hybridization produced in conditions of high stringency.
- condition of low stringency and “conditions of high stringency” are understood by those skilled, but are conveniently exemplified in US 5202257, Col-9-Col 10. If some modifications were made to lead to the expression of a protein with different amino acids, preferably of the same kind of the corresponding amino acids to the SEQ ID No 1; that is, are conservative substitutions. Such substitutions are known by those skilled, for example, see US 5380712, and it is only contemplated when the protein has activity with retinoblastoma protein.
- Preferred DNA or cRNA encodes for a plant Rb protein having A and B pocket sub-domains having between 30% and 75% homology with human Rb protein, particularly as compared with p130, more preferably from 50% to 64% homology.
- the plant Rb protein so encoded has the C706 amino acid of human Rb conserved.
- the spacer sequence between the A and B pockets is not conserved with respect to animal Rb proteins, preferably being less than 50% homologous to the same region as found in such animal proteins
- the protein so encoded has 80% or more homology with that of SEQ NO 2 of the sequence listing attached hereto, still more preferably 90% or more and most preferably 95% or more.
- a third aspect of the present invention there is provided the protein expressed by the recombinant DNA or RNA of the second aspect, novel proteins derived from such DNA or RNA, and protein derived from naturally occurring DNA or RNA by mutagenic means such as use of mutagenic PCR primers.
- vectors, cells and plants and animals comprising the recombinant DNA or
- RNA of correct sense or anti-sense, of the invention RNA of correct sense or anti-sense, of the invention
- a method of controlling cell or viral growth comprising administering the DNA, RNA or protein of the second or third aspects to the cell
- administration may be direct in the case of proteins or may involve indirect means, such as electroporation of plant seed cells with DNA or by transformation of cells with expression vectors capable of expressing or over expressing the proteins of the invention or fragments thereof that are capable of inhibiting cell or viral growth
- the method uses an expression vector capable of producing anti-sense RNA of the cDNA of the invention
- Another one of the specific characteristics of the plants protein and of the nucleic acids includes a N- terminal domain corresponding in sequence to the amino acids 1 to 90 of the SEQ ID No 2 and a nucleotides sequence corresponding to the basis 31 to 300 of the SEQ ID No 1 These sequences are characterized by possessing less than 150 and less than 450 units that the animal sequences which possess more than 300 amino acids and 900 pairs of more bases.
- Fig 1 The sub-figure a shows the relative lengths of the present ZmRb1 protein and the human retinoblastoma proteins
- the sub-figure B shows the alignment of the amino acids sequences of the Pocket A and Pocket B of the ZmRb1 with that of the Xenopus, chicken, rat and three human protein (Rb, p107 and p130).
- Fig. 2 This figure is a map of the main characteristics of the WDV virus and the pWori vector derived from WDV and the positions of the deletions and mutations used in order to establish that the LXCXE motif is required for its replication in plants cells.
- oligonucleotides designed to be complementary to a known EST sequence of homologue maize of pl30. These oligonucleotides were 5'-AATAGACACATCGATCAA/G (M.5m, nt positions 1411-1438) and 5'-GTAATGATACCAACATGG (M.3c, nt positions 1606-1590) (Isogen Biosciences).
- pBluescript SK- (pBS) phagemids from positive clones were isolated by in vivo excision with ExAssist helper phage (Stratagene) according to protocols recommended by the manufacturer. DNA sequencing was carried out using a SequenaseTM Kit (USB).
- the 5'-end of the mRNAs encoding p75ZmRb1 was determined by RACE-PCR.
- Poly-A+mRNA was purified by chromatography on oligo-dT-cellulose (Amersham).
- the first strand was synthesized using oligonucleotide DraI35 (5'-GATTTAAAATCAAGCTCC, nt positions 113-96). After denaturation at 90°C for 3 min, RNA was eliminated by RNase treatment, the cDNA recovered and 5'-tailed with terminal transferase and dATP. Then a PCR fragment was amplified using primer DraI35 and the linker-primer (50 bp) of the Stratagene cDNA synthesis kit.
- One of the positive clones so produced contained a -4 kb insert that, according to restriction analysis, extended both 5' and 3' of the region contained in the Expressed Sequence Tag used.
- the nucleotide sequence corresponding to the longest cDNA insert (3747 bp) is shown in SEQ ID No. 1.
- This ZmRb1 cDNA contains a single open reading frame capable of encoding a protein of 683 amino acids (predicted Mr 75247, p75ZmRb1) followed by a 1646 bp 3'-untranslated region. Untranslated regions of similar length have been also found in mammalian Rb cDNAs (Lee, W.-L. et al, Science 235, 1394 (1987); Bernards, R.
- Plasmid pWori ⁇ was constructed by deleting in pWori most of the sequences encoding WDV proteins (Sanz and Gutierrez, unpublished).
- Plasmid p35S . Rb1 was constructed by inserting the CaMV 35S promoter (obtained from pWDV3 :35SGUS) upstream of the ZmRb1 cDNA in the pBS vector.
- Plasmid p35S.130 was constructed by introducing the complete coding sequence of human pl30 instead of ZmRb1 sequences into p35S.Rb1.
- Plasmid p35.A+B was constructed by substituting sequences encoding the WDV RepA and RepB ORFs instead of ZmRb1 in p35S.Rb1 plasmid. (See Soni, R. and Murray, J. A. H. Anal. Biochem. 218, 474-476 (1994)).
- sequence around the methionine codon at nucleotide position 31 contains a consensus translation start
- the ZmRb1 protein contains segments homologous to the A and B subdomains of the "pocket" that is present in all members of the Rb family. These subdomains are separated by a non-conserved spacer. ZmRb1 also contains non- conserved N-terminal and C- terminal domains. Overall, ZmRb1 shares ⁇ 28-30% amino acid identity (-50% similarity) with the Rb family members (Hannon, G. J., Demetrick, D. & Beach, D. Genes Dev. 7, 2378 (1993); Cobrinik, D., Whyte, P., Peeper, D.S., Jacks, T. & Weinberg, R. A. ibid., p. 2392 (1993).
- the 561-577 amino acids encompass a proline-rich domain.
- ZmRb1 contains 16 consensus sites, SP or TP for phosphorilation by cyclins dependant kinases (CDKs) with one of the 5'-tail of the sub-domain A and several in the C-terminal area which are potential sites of phosphorilation.
- CDKs cyclins dependant kinases
- a nucleic acid preferred group which encodes proteins in which one or more of these sites are changed or deleted, making the protein more resistant to the phosphorilation and thus, to its functionality, for example linking to E2F or similar This can be easily carried out by means of mutagenesis conducted by means of PCR.
- the E198K mutant of WDV RepA behaves similarly to analogous point mutants of animal virus oncoproteins (Moran, E , Zerler, B , Harrison, T M and Mathews, M B Mol Cell Biol. 6, 3470 (1986), Cherington, V et al ibid , p 1380 (1988), Lillie, J W , Lowenstein, P M , Green, M R and Green, M Cell 50, 1091 (1987); DeCarpio, J. A. et al., ibid., p. 275 (1988)).
- PCNA proliferating cell nuclear antigen
- the Rb family has been implicated in tumor suppression and in the control of differentiation and development.
- p75ZmRb1 could also play key regulatory roles at other levels during the plant cell life.
- the inventors have noted that the V ⁇ rB4 protein encoded by the Ti plasmids of both Agrobacteri uw tumefaciens and A . rhyzogenes contains an LXCXE motif. Although the V ⁇ rB4 protein is required for tumor induction (Hooykas, P. J. J and Beijersbergen, A G. M.
- WDV wheat dwarf geminivirus
- Plasmid DNA represents exclusively newly-replicated plasmid DNA since it is fully resistant to Dpnl digestion and sensitive to Mbol. Note that the Mbol-digested samples were run for about half of the length than the undigested samples.
- test plasmid pWori ⁇ (which does not encode functional WDV replication proteins but replicates when they are provided by a different plasmid, i. e.
- pWori pWori ⁇
- pWori ⁇ pWori ⁇
- p35S.A+B 6 g
- p35S.Rb1 10 g
- p35S.130 10 g
- Replication of the test plasmid (pWori ⁇ ) was analyzed 36 hours after transfection and was detected as described in part A using ethidium bromide staining; Southern hybridization.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ333100A NZ333100A (en) | 1996-06-13 | 1997-06-12 | Plant retinoblastoma-associated proteins and their use in modulating the cell cycle of a plant |
| AU32579/97A AU721332B2 (en) | 1996-06-13 | 1997-06-12 | Plant retinoblastoma-associated proteins |
| BR9710848-0A BR9710848A (pt) | 1996-06-13 | 1997-06-12 | Proteìnas de retinoblastoma associado vegetal. |
| EP97928187A EP0914436A1 (fr) | 1996-06-13 | 1997-06-12 | Proteines vegetales associees au retinoblastome |
| JP10501212A JP2001502522A (ja) | 1996-06-13 | 1997-06-12 | 網膜芽細胞腫関連植物蛋白 |
| US09/213,293 US6384299B1 (en) | 1996-06-13 | 1998-12-14 | Plant retinoblastoma-associated gene |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002257972A CA2257972A1 (fr) | 1996-06-13 | 1996-06-13 | Proteines vegetales |
| PCT/ES1996/000130 WO1997047647A1 (fr) | 1996-06-13 | 1996-06-13 | Proteines vegetales |
| ESPCT/ES96/00130 | 1996-06-13 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/213,293 Continuation US6384299B1 (en) | 1996-06-13 | 1998-12-14 | Plant retinoblastoma-associated gene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1997047745A1 true WO1997047745A1 (fr) | 1997-12-18 |
Family
ID=25680704
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/ES1996/000130 WO1997047647A1 (fr) | 1996-06-13 | 1996-06-13 | Proteines vegetales |
| PCT/EP1997/003070 WO1997047745A1 (fr) | 1996-06-13 | 1997-06-12 | Proteines vegetales associees au retinoblastome |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/ES1996/000130 WO1997047647A1 (fr) | 1996-06-13 | 1996-06-13 | Proteines vegetales |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0914436A1 (fr) |
| CN (1) | CN1227605A (fr) |
| AU (1) | AU721332B2 (fr) |
| CA (2) | CA2257972A1 (fr) |
| WO (2) | WO1997047647A1 (fr) |
| ZA (1) | ZA975202B (fr) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998042851A1 (fr) * | 1997-03-26 | 1998-10-01 | Cambridge University Technical Services Ltd. | Plantes presentant une croissance modifiee |
| WO1998056811A3 (fr) * | 1997-06-12 | 1999-03-04 | Consejo Superior Investigacion | Proteines vegetales grab |
| WO1999013083A3 (fr) * | 1997-09-05 | 1999-05-06 | Cropdesign Nv | Methode et dispositif de modulation de proteines de cycle cellulaire vegetal et leur utilisation dans la regulation de la croissance de cellules vegetales |
| WO1999058681A3 (fr) * | 1998-05-08 | 1999-12-29 | Consejo Superior Investigacion | Cellules de plantes transgeniques exprimant un peptide e2f vegetal recombinant |
| WO1999066055A3 (fr) * | 1998-06-15 | 2000-03-02 | Cropdesign Nv | Sequences de regulation inductibles par des pathogenes de vegetaux, liees de maniere operationnelle a des genes du cycle cellulaire, et utilisation desdites sequences |
| WO1999053069A3 (fr) * | 1998-04-09 | 2000-03-23 | Du Pont | Proteines de regulation du cycle cellulaire |
| WO2000053784A1 (fr) * | 1999-03-12 | 2000-09-14 | Pioneer Hi-Bred International, Inc. | Methodes d'utilisation d'une replicase virale |
| WO2000050614A3 (fr) * | 1999-02-25 | 2000-12-14 | Pioneer Hi Bred Int | Procedes d'utilisation de polynucleotides et de polypeptides de replicase virale |
| US6696560B1 (en) | 1999-03-19 | 2004-02-24 | The United States Of America As Represented By The United States Department Of Energy | Retinoblastoma-like RRB gene of arabidopsis thaliana |
| WO2004016775A3 (fr) * | 2002-08-14 | 2004-05-06 | Cropdesign Nv | Vegetaux a croissance modifiee et leur methode d'elaboration |
| US7888460B2 (en) | 1999-10-01 | 2011-02-15 | Isis Innovation Limited | Diagnostic and therapeutic epitope, and transgenic plant |
| US9017690B2 (en) | 2004-04-28 | 2015-04-28 | Btg International Limited | Epitopes related to coeliac disease |
| US10053497B2 (en) | 2002-06-05 | 2018-08-21 | Oxford University Innovation Limited | Therapeutic epitopes and uses thereof |
| US10105437B2 (en) | 2004-04-28 | 2018-10-23 | Btg International Limited | Epitopes related to coeliac disease |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030167505A1 (en) * | 2001-03-16 | 2003-09-04 | Dilkes Brian R. | Cell cycle nucleic acids, polypeptides and uses thereof |
| CN112119163A (zh) * | 2018-02-16 | 2020-12-22 | 首尔大学校产学协力团 | 产量提高的转基因植物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992005272A1 (fr) * | 1990-09-17 | 1992-04-02 | The Regents Of The University Of California | Procede et composition permettant de maitriser la proliferation cellulaire |
| WO1995006661A1 (fr) * | 1993-09-03 | 1995-03-09 | Research Development Foundation | MUTANTS DES GENES Rb ET p53 ET LEURS UTILISATIONS |
| WO1995007708A2 (fr) * | 1993-09-13 | 1995-03-23 | The Regents Of The University Of California | Utilisation therapeutique d'un produit genique contre la predisposition au retinoblastome |
-
1996
- 1996-06-13 WO PCT/ES1996/000130 patent/WO1997047647A1/fr active Search and Examination
- 1996-06-13 CA CA002257972A patent/CA2257972A1/fr not_active Abandoned
-
1997
- 1997-06-12 CA CA002257828A patent/CA2257828A1/fr not_active Abandoned
- 1997-06-12 ZA ZA975202A patent/ZA975202B/xx unknown
- 1997-06-12 CN CN97197141A patent/CN1227605A/zh active Pending
- 1997-06-12 WO PCT/EP1997/003070 patent/WO1997047745A1/fr not_active Application Discontinuation
- 1997-06-12 EP EP97928187A patent/EP0914436A1/fr not_active Withdrawn
- 1997-06-12 AU AU32579/97A patent/AU721332B2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992005272A1 (fr) * | 1990-09-17 | 1992-04-02 | The Regents Of The University Of California | Procede et composition permettant de maitriser la proliferation cellulaire |
| WO1995006661A1 (fr) * | 1993-09-03 | 1995-03-09 | Research Development Foundation | MUTANTS DES GENES Rb ET p53 ET LEURS UTILISATIONS |
| WO1995007708A2 (fr) * | 1993-09-13 | 1995-03-23 | The Regents Of The University Of California | Utilisation therapeutique d'un produit genique contre la predisposition au retinoblastome |
Non-Patent Citations (9)
| Title |
|---|
| "AC T18395", EMBL DATABASE, 23 April 1994 (1994-04-23), HEIDELBERG * |
| COLLIN S. ET AL.: "The two nonstructural proteins from wheat dwarf virus involved in viral gene expression and replication are retinoblastoma-binding proteins", VIROLOGY, vol. 219, no. 1, 1 May 1996 (1996-05-01), pages 324 - 329, XP002042539 * |
| GRAFI G. ET AL.: "A maize cDNA encoding a member of the retinoblastoma protein family: involvement in endoreduplication", PNAS, U.S.A., vol. 93, no. 17, 20 August 1996 (1996-08-20), pages 8962 - 8967, XP002042542 * |
| GRAFI G. ET AL.: "AC U52099", EMBL DATABASE, 26 April 1996 (1996-04-26), HEIDELBERG, XP002042537 * |
| QIAN Y ET AL: "BIOLOGICAL FUNCTION OF THE RETINOBLASTOMA PROTEIN REQUIRES DISTINCT DOMAINS FOR HYPERPHOSPHORYLATION AND TRANSCRIPTION FACTOR BINDING", MOLECULAR AND CELLULAR BIOLOGY, vol. 12, no. 12, pages 5363 - 5372, XP000615356 * |
| SHEN B. ET AL.: "Partial sequencing and mapping of clones from two maize cDNA libraries", PLANT MOLECULAR BIOLOGY, vol. 26, no. 4, November 1994 (1994-11-01), pages 1085 - 1101, XP002042536 * |
| SONI R. ET AL.: "A family of cyclin D homologs from plants differentially controlled by growth regulators and containing the conserved retinoblastoma protein interaction motif", THE PLANT CELL, vol. 7, no. 1, January 1995 (1995-01-01), pages 85 - 103, XP002042540 * |
| XIE Q. ET AL.: "Identification and analysis of a retinoblastoma binding motif in the replication protein of a plant DNA virus: requirement for efficient viral replication", THE EMBO JOURNAL, vol. 14, no. 16, 15 August 1995 (1995-08-15), pages 4073 - 4082, XP002042538 * |
| XIE Q. ET AL.: "Plant cells contain a novel member of the retinoblastoma family of growth regulatory proteins", THE EMBO JOURNAL, vol. 15, no. 18, 16 September 1996 (1996-09-16), pages 4900 - 4908, XP002042541 * |
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998042851A1 (fr) * | 1997-03-26 | 1998-10-01 | Cambridge University Technical Services Ltd. | Plantes presentant une croissance modifiee |
| US6559358B1 (en) | 1997-03-26 | 2003-05-06 | Cambridge University Technical Services, Ltd. | Plants with modified growth |
| EA003425B1 (ru) * | 1997-03-26 | 2003-04-24 | Кембридж Юниверсити Текникал Сервисиз Лимитед | Химерный ген, обеспечивающий экспрессию в растениях циклина d-типа, и способ получения растений с измененными ростовыми свойствами при использовании указанного гена |
| WO1998056811A3 (fr) * | 1997-06-12 | 1999-03-04 | Consejo Superior Investigacion | Proteines vegetales grab |
| WO1999013083A3 (fr) * | 1997-09-05 | 1999-05-06 | Cropdesign Nv | Methode et dispositif de modulation de proteines de cycle cellulaire vegetal et leur utilisation dans la regulation de la croissance de cellules vegetales |
| WO1999053069A3 (fr) * | 1998-04-09 | 2000-03-23 | Du Pont | Proteines de regulation du cycle cellulaire |
| WO1999053075A3 (fr) * | 1998-04-09 | 2000-03-23 | Du Pont | Proteines de regulation du cycle cellulaire cdc-16, dp-1, dp-2 et e2f tirees de plantes |
| WO1999058681A3 (fr) * | 1998-05-08 | 1999-12-29 | Consejo Superior Investigacion | Cellules de plantes transgeniques exprimant un peptide e2f vegetal recombinant |
| WO1999066055A3 (fr) * | 1998-06-15 | 2000-03-02 | Cropdesign Nv | Sequences de regulation inductibles par des pathogenes de vegetaux, liees de maniere operationnelle a des genes du cycle cellulaire, et utilisation desdites sequences |
| AU757829B2 (en) * | 1998-06-15 | 2003-03-06 | Cropdesign N.V. | Plant pathogen inducible control sequences operably linked to cell cycle genes and the uses thereof |
| AU747844B2 (en) * | 1999-02-25 | 2002-05-23 | Arizona Board Of Regents On Behalf Of The University Of Arizona, The | Methods of using viral replicase polynucleotides and polypeptides |
| US6284947B1 (en) | 1999-02-25 | 2001-09-04 | Pioneer Hi-Bred International, Inc. | Methods of using viral replicase polynucleotides and polypeptides |
| WO2000050614A3 (fr) * | 1999-02-25 | 2000-12-14 | Pioneer Hi Bred Int | Procedes d'utilisation de polynucleotides et de polypeptides de replicase virale |
| US7309813B2 (en) | 1999-02-25 | 2007-12-18 | Pioneer Hi-Bred International, Inc. | Methods of using viral replicase polynucleotides and polypeptides |
| WO2000053784A1 (fr) * | 1999-03-12 | 2000-09-14 | Pioneer Hi-Bred International, Inc. | Methodes d'utilisation d'une replicase virale |
| US6770800B2 (en) | 1999-03-12 | 2004-08-03 | Pioneer Hi-Bred International, Inc. | Methods of using viral replicase polynucleotides and polypeptides |
| US6696560B1 (en) | 1999-03-19 | 2004-02-24 | The United States Of America As Represented By The United States Department Of Energy | Retinoblastoma-like RRB gene of arabidopsis thaliana |
| US7888460B2 (en) | 1999-10-01 | 2011-02-15 | Isis Innovation Limited | Diagnostic and therapeutic epitope, and transgenic plant |
| US8329144B2 (en) | 1999-10-01 | 2012-12-11 | Isis Innovation Limited | Diagnostic and therapeutic epitope, and transgenic plant |
| US10053497B2 (en) | 2002-06-05 | 2018-08-21 | Oxford University Innovation Limited | Therapeutic epitopes and uses thereof |
| WO2004016775A3 (fr) * | 2002-08-14 | 2004-05-06 | Cropdesign Nv | Vegetaux a croissance modifiee et leur methode d'elaboration |
| US9017690B2 (en) | 2004-04-28 | 2015-04-28 | Btg International Limited | Epitopes related to coeliac disease |
| US10105437B2 (en) | 2004-04-28 | 2018-10-23 | Btg International Limited | Epitopes related to coeliac disease |
Also Published As
| Publication number | Publication date |
|---|---|
| AU3257997A (en) | 1998-01-07 |
| ZA975202B (en) | 1998-12-14 |
| EP0914436A1 (fr) | 1999-05-12 |
| CA2257972A1 (fr) | 1997-12-18 |
| AU721332B2 (en) | 2000-06-29 |
| WO1997047647A1 (fr) | 1997-12-18 |
| CN1227605A (zh) | 1999-09-01 |
| CA2257828A1 (fr) | 1997-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1997047745A1 (fr) | Proteines vegetales associees au retinoblastome | |
| US7732663B2 (en) | Cyclin-dependent kinase inhibitors as plant growth regulators | |
| SK131799A3 (en) | Plants with modified growth | |
| BRPI0618328A2 (pt) | método para melhorar caracterìsticas de crescimento de planta em relação às plantas do tipo selvagem correspondentes, construção, célula hospedeira, método para produzir uma planta transgênnica, parte de planta ou célula de planta tendo caracterìsticas de crescimento de planta melhoradas em relação às plantas do tipo selvagem correspondentes, e, usos de uma construção e de um ácido nucleico | |
| CN112424365A (zh) | 核酸构建体及其使用方法 | |
| CA2220333A1 (fr) | Promoteur de plantes active par infection fongique | |
| KR100990370B1 (ko) | 벼 도열병균에 대한 내성을 증진시키는 유전자 및 이의용도 | |
| JP2002506345A (ja) | 植物grabタンパク質 | |
| EP1179003B1 (fr) | Procedes pour accroitre la proliferation de cellules vegetales par inhibition fonctionnelle d'un gene inhibiteur de la cycline vegetale | |
| JP2002514423A (ja) | 組換え植物e2fペプチドを発現するトランスジェニック植物細胞 | |
| US6384299B1 (en) | Plant retinoblastoma-associated gene | |
| EP1214436A2 (fr) | Proteines du reactif associe de dimerisation (dp) du ble et utilisations correspondantes | |
| Gutiérrez Armenta et al. | Plant retinoblastoma-associated gene | |
| CN114716522A (zh) | Kin10蛋白及其相关生物材料在植物耐盐碱中的应用 | |
| WO2000018886A1 (fr) | Gene de detoxication xenobiotique provenant de plantes | |
| AU1347999A (en) | Root-specific promoter | |
| CN111607598A (zh) | 大豆DDT结构域基因GmDDT1的应用 | |
| CN114645029B (zh) | 分离人工合成的MpgS蛋白质多肽和MpgP蛋白质多肽及其应用 | |
| Gutiérrez Armenta et al. | Plant proteins | |
| CN114657209B (zh) | 蛋白rar1及其相关物质在调控植物耐逆性或培育高耐逆性植物中的应用 | |
| CN113151269B (zh) | 一种百子莲脱水素蛋白ApSK3基因的启动子序列及其用途 | |
| CN113667675B (zh) | 利用大豆fls2/bak1基因提高植物抗病性 | |
| US6410717B1 (en) | Gene encoding a host factor protein indispensable for multiplication of a plant virus | |
| Gutiérrez Armenta et al. | Plant retinoblastoma-associated proteins | |
| CN113151268A (zh) | 一种百子莲脱水素ApY2SK2基因启动子序列及其用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 97197141.2 Country of ref document: CN |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 333100 Country of ref document: NZ |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1997928187 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2257828 Country of ref document: CA Ref document number: 2257828 Country of ref document: CA Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PA/A/1998/010582 Country of ref document: MX |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09213293 Country of ref document: US |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: 1997928187 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1997928187 Country of ref document: EP |